Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,676.00
Bid: 1,672.40
Ask: 1,672.80
Change: 0.00 (0.00%)
Spread: 0.40 (0.02%)
Open: 1,679.60
High: 1,686.40
Low: 1,667.80
Yest. Close: 1,685.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GSK to update on potential cancer treatment at European congress

Wed, 12th Jun 2019 12:34

(Sharecast News) - GlaxoSmithKline is to present studies on a potential breakthrough cancer treatment at a major conference, the drugs giant confirmed on Wednesday. GSK said new data on belantamab mafodotin, an investigational anti-BCMA antibody-drug conjugate being tested on patients with relapsed/refractory multiple myeloma, would be presented at this year's European Hematology Association Congress. The treatment is not approved for use anywhere in the world. But in 2017 it was awarded breakthrough therapy designation by the US Food and Drug Administration and PRIME designation by the European Medicines Agency, and is undergoing clinical trials. Research being presented at the EHA Congress includes patient reported experience as well as studies looking at the effectiveness of the treatment. The UK's biggest drug company reported full-year sales of more than �30bn in February, but at the time warned that generic competition would hurt its blockbuster asthma treatment. The blue chip is looking to strengthen its pipeline of new drugs, with a particular focus on immunology, genetics and new technologies. It is selling its consumer healthcare business, which includes brands such as Horlicks, to Unilever, and earlier this year said it had doubled the amount of oncology assets in clinical development to 16 since July 2018. The 24th EHA Congress will be held in Amsterdam on 13 - 16 June.

More News

Glaxo's ViiV Reports Positive Study Results Of HIV-Treatment Regimen

(Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare reported positive headline results from its global phase III ATLAS-2M study.ViiV Healthcare is a specialist HIV owned

22 Aug 19 08:20

GlaxoSmithKline upbeat on latest test results from ViiV Healthcare

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

22 Aug 19 07:29

Glaxo Submits Japanese Application For Daprodustat Anaemia Drug

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it has submitted a new drug application in Japan for anaemia drug daprodustat.The application was submitted to the Japanese Ministry

21 Aug 19 08:38

GlaxoSmithKline seeking marketing approval for 'daprodustat' in Japan

(Sharecast News) - GlaxoSmithKline announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare on Wednesday, seeking marketing approval for 'daprodustat'.

21 Aug 19 08:07

WINNERS & LOSERS SUMMARY: Plus500 Up On Share Buyback, New Customers

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------TUI, up

13 Aug 19 10:09

LONDON MARKET OPEN: TUI And Plus500 Both Rise Despite Profit Falls

(Alliance News) - Stock prices in London opened lower on Tuesday as concerns about the US-China trade war, protests in Hong Kong, and fears of a global economic slowdown continue to sap sentiment.

13 Aug 19 08:43

Glaxo US Pharma Head To Leave Role, Poaches Merck KGaA Oncology Head

(Alliance News) - GlaxoSmithKline PLC said on Monday that the head of its US pharmaceuticals division Jack Bailey will step down at the end of the year and will be replaced by Merck KGaA's the

12 Aug 19 17:00

MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director

(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.Duchesne was chief executive of the of May.

31 Jul 19 15:54

GlaxoSmithKline Notes Positive Tango And Gemini HIV Study Results

(Alliance News) - GlaxoSmithKline PLC on Wednesday noted positive results from the Gemini and Tango phase three studies of a dolutegravir plus lamivudine in HIV patients.The results were by

24 Jul 19 17:20

TOP NEWS: GlaxoSmithKline Profit Up In First Half; Guidance Improved

(Alliance News) - GlaxoSmithKline PLC on Wednesday said its profit rose almost 50% in the first half of the year due to strong performances from its Vaccines and Consumer Healthcare also upgraded

24 Jul 19 12:35

LONDON MARKET MIDDAY: Miners Press FTSE Deeper Into Red On Vale News

(Alliance News) - Miners put the FTSE 100 under pressure on Wednesday while the FTSE 250 battled to stay in the green in the face of a 24% slump for luxury car maker Aston large-cap FTSE a

24 Jul 19 11:53

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a

24 Jul 19 10:34

GlaxoSmithKline's ViiV Healthcare Gets Positive Fostemsavir Results

(Alliance News) - GlaxoSmithKline PLC on Monday said its ViiV Healthcare has seen positive results from the phase three Brighte study of investigational fostemsavir in heavily adults with is HIV a

22 Jul 19 17:19

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 July Scieifitic Digital Imaging Half Year ResultsAudioboomHalf Year Year

17 Jul 19 16:07

Mereo BioPharma Names Richard Francis As New Pharmaceutical Head

(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was

16 Jul 19 14:46

Login to your account

Don't have an account? Click here to register.